Prescriber Update - Medsafe
Prescriber Update 2010; 31(2) June 12 • Height, weight and appetite should be recorded at least every six months. Patients who are not gaining height or weight as expected may need
Download Prescriber Update - Medsafe
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
240510-Efficacy dementia drugs Drugs avoid …
www.dementiacarestrategies.comMore. . . Copyright © 2008 by Therapeutic Research Center Pharmacist’s Letter / Prescriber’s Letter ~ P.O. Box 8190, Stockton, CA 95208 ~ Phone: 209-472-2240 ~ Fax: 209-472-2249
The Joint Commission Update - gotocei.org
www.gotocei.orgThe Joint Commission Update ACPE UAN 0107-0000-10-002-L04-P & 0107-0000-10-002-L04-T 0.2 CEUs/2.0 Hrs. Activity Type: Knowledge-Based Program Objectives for Pharmacists & Technicians: Upon completion of this program, participants should
NARCOTICS MONITORING SYSTEM (NMS) …
www.health.gov.on.caMinistry of Health and Long-Term Care . NARCOTICS MONITORING SYSTEM (NMS) Pharmacy Reference Manual . May 24, 2012 . Version 1.2 Page 1 of 27
DISPENSING MIFEGYMISO - OCPInfo.com
www.ocpinfo.comDISPENSING MIFEGYMISO® Guidance for Pharmacy Professionals Who Are Dispensing Mifegymiso® UPDATED ON: November 13, 2017
NARCOTICS MONITORING SYSTEM - OCPInfo.com
www.ocpinfo.comPATCH4PATCH Fentanyl, a prescription-only drug, is a synthetic opioid used primar - ily to treat severe pain. Fentanyl is available in many forms, including